Literature DB >> 25821224

FcγRIIB prevents inflammatory type I IFN production from plasmacytoid dendritic cells during a viral memory response.

Marcella Flores1, Claude Chew1, Kevin Tyan1, Wu Qing Huang1, Aliasger Salem2, Raphael Clynes3.   

Abstract

The type I IFN (IFN-α) response is crucial for viral clearance during primary viral infections. Plasmacytoid dendritic cells (pDCs) are important early responders during systemic viral infections and, in some cases, are the sole producers of IFN-α. However, their role in IFN-α production during memory responses is unclear. We found that IFN-α production is absent during a murine viral memory response, despite colocalization of virus and pDCs to the splenic marginal zone. The absence of IFN was dependent on circulating Ab and was reversed by the transgenic expression of the activating human FcγRIIA receptor on pDCs. Furthermore, FcγRIIB was required for Sendai virus immune complex uptake by splenic pDCs in vitro, and internalization via FcγRIIb prevented cargo from accessing TLR signaling endosomes. Thus, pDCs bind viral immune complexes via FcγRIIB and prevent IFN-α production in vivo during viral memory responses. This Ab-dependent IFN-α regulation may be an important mechanism by which the potentially deleterious effects of IFN-α are prevented during a secondary infection.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25821224      PMCID: PMC4820833          DOI: 10.4049/jimmunol.1401296

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  45 in total

1.  Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.

Authors:  Gaetan Jego; A Karolina Palucka; Jean-Philippe Blanck; Cecile Chalouni; Virginia Pascual; Jacques Banchereau
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

2.  Tissue-specific positive feedback requirements for production of type I interferon following virus infection.

Authors:  Arun Prakash; Eric Smith; Chien-Kuo Lee; David E Levy
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

3.  The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model.

Authors:  S E McKenzie; S M Taylor; P Malladi; H Yuhan; D L Cassel; P Chien; E Schwartz; A D Schreiber; S Surrey; M P Reilly
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  Interferon function is not required for recovery from a secondary poxvirus infection.

Authors:  Vijay Panchanathan; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-25       Impact factor: 11.205

5.  Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

Authors:  Anne Krug; Gary D Luker; Winfried Barchet; David A Leib; Shizuo Akira; Marco Colonna
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

6.  IgG-derived Fc down-regulates virus-induced plasmacytoid dendritic cell (pDC) IFNalpha production.

Authors:  Daniel S Green; Tom Lum; Jon A Green
Journal:  Cytokine       Date:  2004-06-07       Impact factor: 3.861

7.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.

Authors:  A Takeda; C U Tuazon; F A Ennis
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

Review 8.  Plasmacytoid dendritic cells in immunity.

Authors:  Marco Colonna; Giorgio Trinchieri; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2004-12       Impact factor: 25.606

9.  Type I interferon dependence of plasmacytoid dendritic cell activation and migration.

Authors:  Carine Asselin-Paturel; Géraldine Brizard; Karine Chemin; Andre Boonstra; Anne O'Garra; Alain Vicari; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2005-03-28       Impact factor: 14.307

10.  Impaired antibody response causes persistence of prototypic T cell-contained virus.

Authors:  Andreas Bergthaler; Lukas Flatz; Admar Verschoor; Ahmed N Hegazy; Martin Holdener; Katja Fink; Bruno Eschli; Doron Merkler; Rami Sommerstein; Edit Horvath; Marylise Fernandez; André Fitsche; Beatrice M Senn; J Sjef Verbeek; Bernhard Odermatt; Claire-Anne Siegrist; Daniel D Pinschewer
Journal:  PLoS Biol       Date:  2009-04-07       Impact factor: 8.029

View more
  5 in total

Review 1.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

Review 2.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

3.  Shenqi Fuzheng Injection (SFI) Enhances IFN-α Inhibitory Effect on Hepatocellular Carcinoma Cells by Reducing VEGF Expression: Validation by Gene Silencing Technique.

Authors:  Xiaoheng Chen; Shuo Qi; Zhe Li; Bei He; Hui Long Li; Jinxiang Fu; Sheng Huang; Lei Zhang; Xinai Li; Rui Hu; Lu Li; Tangshun Wang; Feng Xue; Xiang Gao; Xiaoguang Shi; Tao Zhang; Xin Wang; Junhui Wang; Zhiguo Ding
Journal:  Biomed Res Int       Date:  2019-04-23       Impact factor: 3.411

4.  Blood Interferon Signatures Putatively Link Lack of Protection Conferred by the RTS,S Recombinant Malaria Vaccine to an Antigen-specific IgE Response.

Authors:  Darawan Rinchai; Scott Presnell; Marta Vidal; Sheetij Dutta; Virander Chauhan; David Cavanagh; Gemma Moncunill; Carlota Dobaño; Damien Chaussabel
Journal:  F1000Res       Date:  2015-09-29

5.  Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells.

Authors:  Melissa Newling; Willianne Hoepel; Lisa T C Vogelpoel; Marieke H Heineke; Johan A van Burgsteden; Esther W M Taanman-Kueter; Dirk Eggink; Taco W Kuijpers; Tim Beaumont; Marjolein van Egmond; Martien L Kapsenberg; Dominique L P Baeten; Jeroen den Dunnen; Esther C de Jong
Journal:  Eur J Immunol       Date:  2018-09-14       Impact factor: 5.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.